Kiadis Pharma N.V. | Mutual Funds
Mutual Funds that own Kiadis Pharma N.V.
BNP Paribas B - Pension Balanced
84,073
0.42%
0
0.03%
09/29/2017
62,679
0.31%
62,679
0.49%
06/29/2018
GO UCITS ETF Solutions Plc - DAXglobal Gold Mining Fund
60,117
0.3%
60,117
0.39%
02/28/2018
41,691
0.21%
0
0.12%
07/31/2018
Rhenman & Partners Fund - Healthcare Equity L/S
36,135
0.18%
36,135
0.03%
12/31/2017
21,620
0.11%
21,620
0.1%
06/30/2017
Metropolitan - Rentastro Growth
19,547
0.1%
0
0.02%
07/31/2018
GO UCITS ETF Solutions Plc - Longer Dated All Commodities
14,033
0.07%
14,033
0.03%
02/28/2018
BNP Paribas B - Pension Growth
10,139
0.05%
0
0.02%
09/29/2017
BNP Paribas B - Pension Stability
5,981
0.03%
0
0.02%
09/29/2017
| Address |
Paasheuvelweg 25
Amsterdam Noord-Holland 1105 BP
Netherlands
|
|
Employees
|
- |
| Website |
http://www.kiadis.com |
| Updated |
07/08/2019 |
| Kiadis Pharma NV is a clinical stage biopharmaceutical company. It engages in the research, development, and future commercialization of cell-based immunotherapy products for treatment of blood cancers and inherited blood disorders. The company provide the products for Allodepleted T-cell ImmunotheRapeutics that are based on its theralux platform. |
